| Literature DB >> 11950561 |
Dana C Andersen1, Lynne Krummen.
Abstract
In recent years, the number of recombinant proteins used for therapeutic applications has increased dramatically. Many of these applications involve complex glycoproteins and antibodies with relatively high production needs. These demands have driven the development of a variety of improvements in protein expression technology, particularly involving mammalian and microbial culture systems.Entities:
Mesh：
Substances：
Year: 2002 PMID： 11950561 DOI： 10.1016/s0958-1669(02)00300-2
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN： 0958-1669 Impact factor: 9.740